ESC Premium Access

New applications of risk assessment in coronary artery disease

Event: ESC CONGRESS 2019
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Moderated Posters
Date: 1 September 2019
Time: 12:40 - 13:30

Congress Session

6 presentations in this session

How to improve early prediction of heart failure development after STEMI in clinical arena-is there a place for myocardial deformation imaging?

Speaker: Assistant Professor D. Trifunovic (Belgrade, RS)
Thumbnail

Serial left ventricular global longitudinal strain and mortality in patients with Takotsubo cardiomyopathy

Speaker: Doctor N. Isaza (Boston, US)
Thumbnail

Value of GRACE risk score in risk stratification in acute coronary syndrome patients undergoing PCI in the Global Leaders study

Speaker: Doctor Y. Onuma (Galway, IE)
Thumbnail

Risk of upper gastrointestinal bleeding following myocardial infarction: a novel prediction model for assessing appropriateness of proton pump inhibition therapy

Speaker: Doctor T. Sehested (Copenhagen, DK)
Thumbnail

Prognostic value of the CHADS2 score for adverse cardiovascular events in acute myocardial infarction patients without atrial fibrillation: J-MINUET Substudy

Speaker: Doctor K. Motozato (Kumamoto, JP)
Thumbnail

The CHADS-VASc score is a predictor of No-Reflow in patients with NSTEMI

Speaker: Doctor H. Barman (Istanbul, TR)
Thumbnail

6 speakers from this session

Assistant Professor Danijela Trifunovic

Clinical center of Serbia, Belgrade (Serbia)
0 follower

Doctor Nicolas Isaza

Beth Israel Deaconess Medical Center & Harvard Medical School, Boston (United States of America)
0 follower

Doctor Yoshinobu Onuma

National University of Ireland, Galway (Ireland)
0 follower

Doctor Thomas Steen Gyldenstierne Sehested

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Doctor Kota Motozato

Kumamoto University Hospital, Kumamoto (Japan)
0 follower

Doctor Hasan Barman

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkey)
0 follower

This platform is supported by

logo Novo Nordisk